J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contract
Johnson & Johnson (J&J) has sued Samsung Bioepis over a ‘concealed plan’ to supply an unnamed health conglomerate with a…
Johnson & Johnson (J&J) has sued Samsung Bioepis over a ‘concealed plan’ to supply an unnamed health conglomerate with a…
Compounders are on alert after the US Food and Drug Administration (FDA) declared the shortage of semaglutide –the active ingredient…
Pfizer will end the global commercialisation of its haemophilia gene therapy Beqvez (fidanacogene elaparvovec) amid low demand and interest. A…
The World Health Organization (WHO) said it will conduct another mass vaccination round in the Gaza Strip to protect children…
A team of US scientists has developed a new foundation model that can sift through genetic code across biology's five…
Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share…
Valneva has met its revenue growth target for 2024, fending off slower-than-expected sales for the chikungunya vaccine Ixchiq. The French…
Bavarian Nordic has won US Food and Drug Administration (FDA) approval for its chikungunya vaccine Vimkunya, becoming the second company…
Galderma has won approval from the European Commission (EC) for subcutaneous injection Nemluvio (nemolizumab) for the treatment of atopic dermatitis…
Already anticipating losing its biggest funder, the World Health Organization’s (WHO) director-general Tedros Adhanom Ghebreyesus has asked the US to…